Linkus lozenges lozenges with mint flavour

Nazione: Armenia

Lingua: inglese

Fonte: Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

Principio attivo:

adhadota vasica, glycyrrhiza glabra, piper longum, viola odorata, hyssopus officinalis, alpinia galanga

Commercializzato da:

Herbion Pakistan Pvt. Ltd.

Codice ATC:

R05CA10

INN (Nome Internazionale):

adhadota vasica, glycyrrhiza glabra, piper longum, viola odorata, hyssopus officinalis, alpinia galanga

Dosaggio:

30mg+ 7mg+ 6mg+ 2mg+ 3mg+ 3mg

Forma farmaceutica:

lozenges with mint flavour

Confezione:

(16/2x8/) blisters

Tipo di ricetta:

OTC

Stato dell'autorizzazione:

Registered

Data dell'autorizzazione:

2019-06-19

Scheda tecnica

LINKUS LOZENGES
(MINT, ORANGE AND HONEY-LEMON FLAVORS)
SUMMARY OF PRODUCT CHARACTERISTICS
1.
NAME OF PREPARATION
LINKUS LOZENGES
И КОЛИЧЕСТВЕННЫЙ СОСТАВ
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
_EACH LOZENGE CONTAINS EXTRACTS OF: _
ACTIVE INGREDIENTS
_MINT _
_HONEY-LEMON _
_ORANGE _
Adhatoda vasica
30 mg
30 mg
30 mg
Glycyrrhiza glabra
7 mg
7 mg
7 mg
Piper longum
6 mg
6 mg
6 mg
Viola odorata
2 mg
2 mg
2 mg
Hyssopus officinalis
3 mg
3 mg
3 mg
Alpinia galanga
3 mg
3 mg
3 mg
_ _
_FOR EXCIPIENTS, SEE 6.1. _
3.
MEDICINAL FORM
Lozenges (mint, orange and honey-lemon flavors)
4.
CLINICAL CHARACTERISTICS
4.1.
THERAPEUTIC INDICATIONS
Symptomatic treatment of respiratory tract diseases, associated with
cough and sore
throat.
4.2.
DOSAGE AND ADMINISTRATION
Dose for adults and children above 12 years
One lozenge every two - three hourly, slowly dissolve till complete
resorption.
Maximum daily dose is 8 lozenges.
4.3.
CONTRAINDICATIONS:
Individual hypersensitivity to the components of the preparation.
Contraindicated in children under 12 years, during pregnancy and
lactation
4.4. SPECIAL INSTRUCTIONS AND SPECIAL SAFETY MEASURES
Preparation contains sucrose so caution should be taken in diabetic
patients and patients
on low caloric diet.
4.5. DRUG AND OTHER FORMS OF INTERACTIONS: Concomitant use with other antitussive preparations (for example,
with codeine) and
preparations which decrease expectorations is not recommended.
4.6. PREGNANCY AND LACTATION:
Contraindicated
4.7. IMPACT ON ABILITY TO DRIVE VEHICLE OR HANDLING POTENTIALLY
HAZARDOUS MECHANISMS:
Not revealed.
4.8. SIDE EFFECTS:
Allergic reactions may occur.
4.9. OVER DOSAGE:
There were no reports of overdoses.
5.
PHARMACOLOGICAL PROPERTIES
5.1. PHARMACODYNAMIC AND PHARMACOKINETIC PROPERTIES The
medicinal
herbal
raw
material,
which
is
a
part
of
the
preparation,
has
anti-
inflammatory, expectorant and mucolytic properties.
5.2. PHARMACOTHERAPEUTIC GROUP
Combinations for cough and cold.
5.3. CODE АТХ: R05X
5.4. PRECLINICAL SAFETY DATA
The Linkus l